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SPRINGER, A. D., J. SCHACHT AND B. W. AGRANOFF. The effect of memory blocking antibiotics and their analogs on 
acetylcholinesterase. PHARMAC. BIOCHEM. BEHAV. 5(1) I -3 ,  1976. - The ability of antibiotics to inhibit 
acetylcholinesterase was measured in homogenates of goldfish brain. Puromycin aminonucleoside was the most potent 
inhibitor followed by puromycin, cycloheximide and acetoxycycloheximide. Puromycin effectively impaired retention of 
active-avoidance learning in goldfish when injected either immediately before or after training, while puromycin 
aminonucleoside did not regardless of injection time. These results suggest that the known amnestic effects of puromycin, 
cycloheximide and acetoxycycloheximide are not a consequence of interference with acetylcholinesterase. 
Acetylcholinesterase M e m o r y  Puromycin Puromycin aminonucleoside Cycloheximide Amnesia 
Aeetoxycyleoheximide Goldfish 
THE use of antibiotics that block protein synthesis to study 
memory formation is a well known approach, but it 
remains uncertain whether the established actions of these 
drugs or some side effects mediate the retention deficit. For 
example, it has been postulated that memory consolidation 
in the goldfish is disrupted by an inhibition of protein 
synthesis produced by puromycin [3]. Other inhibitors of 
protein synthesis such as cycloheximide [2] and acetoxy- 
cycloheximide [3], similarly block memory formation. 
Puromycin has also been reported to interfere with 
cholinergic neuromuscular transmission [ 10], depress post- 
ganglionic responses of the superior cervical ganglion of the 
rat [9] and to inhibit acetylcholinesterase (ACHE) in vitro 
[6,7]. Since memory disruption has been reported to result 
from interference with cholinergic mechanisms in rat brain 
by other agents [4],  these data have been interpreted to 
suggest that puromycin may impair memory fixation not 
via inhibition of protein synthesis but rather via interfer- 
ence with the cholinergic system at the level of AChE 
[6,7]. 
If interference with AChE were the basic mechanism of 
action of puromycin, then one should expect similar 
amnestic agents to share this property, while structural 
derivatives of these antibiotics that do not interfere with 
memory formation should not. We report here the effect on 
AChE of 3 agents, known to be amnestic in the goldfish, 
puromycin, cycloheximide and acetoxycycloheximide, as 
well as the ineffective analog of puromycin, puromycin 
aminonucleoside [ 31. 
METHOD 
Biochemical Assay 
Common goldfish (Carassius auratus) weighing 8 - 1 0  g 
were obtained from Ozark Fisheries (Stoutland, Mo.). For 
AChE assays, brains (approximately 8 0 - 1 0 0  mg) were 
removed following spinal section, collected and homogen- 
ized in 0.32 M sucrose. Cellular debris and nuclei were 
removed by centrifugation at 1000 g for I0 rain. The 
supernatant fraction was used in the determination of 
acetylcholinesterase by the procedure of Ellman, et al. [ 5]. 
Assays were performed at room temperature and the 
reaction was started by the addition of the enzyme 
preparation. Acetylthiocholine and puromycin were pur- 
chased from Sigma Co., St. Louis, Mo., puromycin amino- 
nucleoside and cycloheximide from Nutritional Biochemi- 
cal Co., Cleveland, Ohio. 
Behavioral Assay 
One hundred-eleven goldfish were housed in 750-liter 
tanks for approximately 1 - 2  weeks after arrival and were 
then placed in separate 1.5-liter tanks for 1 - 2  days prior to 
Day 1 of the experiment. They were maintained at 20 ° ± 
I°C in continuous light and were not fed. 
Active-avoidance training was performed in an auto- 
mated aquatic shuttlebox which differed from a previously 
described box [2] in that it contained a 6 mm thick, black 
Plexiglas partition that completely divided the box into 2 
compartments. A 4 x 3 cm hole was centered in the barrier 
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dividing the 2 compar tments .  The bo t tom of the hole was 3 
cm from the f loor of  the tank and the water  level in the 
tank was 5 cm. 
On Day 1 fish were acclimated in individual shut t leboxes 
in the dark for 5 min prior to the onset of  15 training trials. 
Each trial lasted 1 rain and began with 15 sec of  light 
presented on the side o f  the box occupied by the fish, 
fol lowed by 20 sec of  light paired with shock (3.5 v, 60 HZ, 
rms, 100 msec duration,  2.5 sec interpulse interval). An 
escape response was recorded by means of  pho tode tec to r s  
when a fish crossed the barrier in response to shock and an 
avoidance response was recorded when a fish crossed the 
barrier prior to shock onset. Trials were inti t iated every 60 
sec, so that  escape or avoidance responses terminated the 
trial (light and shock off) and initiated an intertrial interval 
of  at least 25 sec of  darkness. 
The fish were divided into 5 groups. Two groups 
received an intracranial injection of  130 ug of  puromycin  
dihydrochlori~te in 10 ul saline (n = 19) or  an equimolar  
amount  of  puromycin  aminonucleoside  (70 ug in 10 ul 
saline; n = 23) immedia te ly  prior to placement  in the 
apparatus. Two groups received an inject ion of puromycin  
(n = 22) or  puromycin  aminonucleoside  (n = 22) 
immedia te ly  fol lowing training. A fifth group did not  
receive any drug t rea tment  (n = 25). The 4 initial groups 
were given 15 retraining trials on Day 4 while the fifth 
group was retrained on Day 8. Previous exper iments  
indicated that a 3 or 7 day t r a in - re t r a in  interval results in 
comparable  re tent ion  in control  fish. 
RESULTS 
The effects of  the antibiot ics  on AChE activity are 
summarized in Fig. 1. The drugs were studied at 3 different  
concent ra t ions  and representative curves are presented. For  
ace toxycyc lohex imide ,  inhibit ion was determined at only 
one concent ra t ion  because of  scarcity of  the substance. All 
of the antibiot ics  examined clearly inhibit ACHE. Analysis 
of  the kinetic data suggest noncompet i t ive  inhibit ion,  but  
does not  ruIe out  some degree o f  mixed inhibit ion.  
Inhibi tor  constants  calculated f rom the data in Fig. 1 
indicate that puromycin  aminonucleoside  is the most 
po ten t  inhibitor ,  while ace toxycyc lohex imide  is the weak- 
est (Table 1). 
A 2 × 2 A N O V A  on mean training avoidances of  the 4 
drug treated groups (Table 2) found that the adminis t ra t ion 
of drugs prior to training did not  affect  acquisit ion 
(ps>0.10) .  Retraining avoidances for the puromycin  and 
puromycin  aminonucleoside  groups were analyzed with a 2 
× 2 ANOVA.  The drug effect achieved significance 
(F(1,82)  = 6.92, p < 0 . 0 2 5 )  indicating the amnestic  effect  of  
puromycin ,  while the effect of injection t ime and the 
interact ion were not  significant (ps>0.50) .  
T A B L E  1 
INHIBITION OF AChE BY ANTIBIOTICS 
Drug Ki 
Puromycin aminonucleoside 1.4 x 10 -4 
Puromycin 3.7 x 10 -~ 
Cycloheximide 7.7 x 10 -~ 
Acetoxycycloheximide 15.3 x 10 -~ 
None Km = 2.7x 10-~ 
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FIG. 1. Inhibition of AChE by antibiotics. AChE was assayed as 
described in Method. c-o no additions; o-o 3 × 10-4M 
acetoxycycloheximide; o-D 3 x 10-4M cycloheximide; ~-. 1 × 
10-4M puromycin aminonucleoside; a-,~ 3 × 10-4M puromycin. 
Protein concentration: 80/zg]ml assay volume~ 
DISCUSSION 
All drugs examined inhibited AChE activi ty in prepara- 
tions of  goldfish brain. Compared to specific AChE 
inhibitors such as eserine or  organophosphates  [8 ] ,  the 
concentrations of  the antibiotics necessary to block AChE 
are several orders of  magnitude higher. This result indicates 
that  AChE is not  a likely site for ant ibiot ic  action. Of  
particular significance is the ability of puromycin  amino- 
nucleoside to inhibit AChE to a greater degree than 
puromycin.  Puromycin  clearly impairs re tent ion of  training 
in goldfish while puromycin  aminonucleoside has no effect  
on memory  whether  it is administered ei ther before or after 
training. This result strongly suggests that the mechanism 
by which puromycin  blocks memory  fixation is unrelated 
to its effect  on ACHE. It should also be noted that 0.2 ~g of  
ace toxycyc lohex imide  [1] or  10 ug of  cyc loheximide  
effectively impair re tent ion  in goldfish [11] .  Since the 
potency of  the glutarimide antibiot ics  to inhibit AChE is in 
converse order,  their abil i ty to block memory  also appears 
unrelated to their  action on ACHE. 
The use of  interventive drugs to study physiological 
mechanisms is never free of the problem that the drug may 
have side effects  o ther  than their known mechanism of  
action. It remains possible that the various macromolecular  
synthesis blocking agents affect memory  format ion by still 
o ther  mechanisms. Whatever the ul t imate mechanism of  
these agents, it appears evident that inhibit ion of  AChE is 
not  the means by which the various antibiotics impair 
memory  fixation,  and for the present, protein synthesis 
inhibit ion remains the most parsimonious explanat ion of  
their action. 
ANTIBIOTICS  AND A C E T Y L C H O L I N E S T E R A S E  
T A B L E  2 
MEAN TRAINING AND RETRAINING AVOIDANCES* 
Training Retraining 
Puromycin Puromycin 
Time of injection Puromycin Aminonucleoside Puromycin Aminonucleoside 
Immediate pretrial 1.53 (0.58) 2.57 (0.50) 2.16 (0.47) 4.30 (0.91) 
Immediate posttrial 1.96 (0.39) 1.73 (0.29) 2.41 (0.62) 4.09 (0.73) 
No treatment 2.20 (0.36) 4.40 (0.61) 
*The mean number of avoidances (standard error in parentheses) are given for each 15 trials. 
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